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Summary 
Lectins such as VVA-B4, which bind N-acetylgalac- 
tosaminyl (GalNAc)-terminated saccharides, selec- 
tively stain the neuromuscular junction, thus defining 
a synapse-specific carbohydrate. In seeking roles for 
this carbohydrate, we asked whether VVA-B4 affected 
the distribution of acetylcholine receptors (AChRs) on 
cultured muscle cells. We found that incubation of my- 
otubes with VVA-B4 induced formation of AChR clus- 
ters and potentiated the effect of a nerve-derived clus- 
tering factor, agrin. Additional experiments implicated 
GalNAc-terminated glycoconjugates as modulators of 
agrin-induced AChR clustering. Enzymatic removal of 
GalNAc residues or treatment with a multivalent pro- 
tein-GalNAc conjugate blocked agrin-induced clus- 
tering, whereas enzymatic unmasking of additional 
GalNAc residues induced clustering in the absence of 
added agrin. Moreover, incubation with agrin led to 
redistribution of VVA-B4-binding material on myo- 
tubes. Together, these results suggest that agrin- 
induced clustering of AChRs involves a GalNAc- 
dependent step. 
Introduction 
Cell surface carbohydrates are likely to play important 
roles in the developing nervous system (Margolis and Mar- 
golis, 1989; Jessell et al., 1990). The enormous diversity 
of glycoconjugate structures found in neural tissue, the 
striking spatiotemporal specificity of their expression pat- 
terns, and the strong evidence for carbohydrate-mediated 
recognition and targeting processes in nonneural tissues 
all favor this idea (Lasky, 1992; Drickamer and Taylor, 
1993; Feizi, 1993). Moreover, carbohydrates have been 
implicated as mediators of adhesive interactions among 
neural cells (e.g., Acheson et al., 1991; Hall et al., 1993). 
Here, we provide evidence that saccharides are involved 
in synaptogenesis. 
We showed previously that lectins specific for N-acetyl- 
galactosaminyl (GalNAc)-terminated saccharides selec- 
tively stain neuromuscular junctions in skeletal muscle, 
thereby defining a synapse-specific arbohydrate (Sanes 
and Cheney, 1982; see also Ribera et al., 1987; Kaupmann 
et al., 1988; (~rne-Finderle and Sketelj, 1993). In contrast, 
lectins with other specificities tain synaptic and extrasyn- 
aptic portions of the muscle fiber surface with similar inten- 
sities, indicating that there is no overall excess of carbohy- 
drate at the synapse (Sanes and Cheney, 1982). Further 
studies showed that the synaptic carbohydrate is associ- 
ated with at least three glycoconjugates that are concen- 
trated at synaptic sites: acetylcholinesterase in the synap- 
tic basal lamina, a GM2-1ike glycolipid in the postsynaptic 
membrane, and an unidentified moiety in the presynaptic 
nerve terminal (Scott et al., 1988, 1990; Kaupmann and 
Jockusch, 1988). Interestingly, whereas interspecific and 
even interstrain variations in glycosylation patterns are 
common (e.g. Fox et al., 1982; HolthSfer, 1983; Ponder 
et al., 1985), the synaptic carbohydrate is phylogenetically 
conserved; GalNac-specific lectins selectively stain neu- 
romuscular junctions in mammals, birds, fish, reptiles, and 
amphibians (Scott et al., 1988). Moreover, a GalNAc trans- 
ferase is itself concentrated at neuromuscular junctions, 
and its expression is regulated by synaptic interactions 
(Scott et at., 1990). 
The phylogenetic onservation of the synaptic carbohy- 
drate, its association with several molecules, and the neu- 
ral control of its expression all suggest that GalNAc- 
terminated sugars play a role at the neuromuscular 
junction, but none has been demonstrated to date. To 
initiate functional studies, we used cells of a mouse myo- 
genic line, C2 (Yaffe and Saxel, 1977; Blau et al., 1985). C2 
myotubes assemble high density aggregates of AChRs, 
sometimes called hot spots, many of which are associated 
with cytoskeletal and basal lamina components that are 
also synapse associated in vivo (Silberstein et al., 1982; 
Inestrosa et al., 1983; Gordon et al., 1993). Some hot spots 
form spontaneously, but their number can be increased 
by innervation or incubation with soluble neural extracts 
(Gordon et al., 1993), making C2 cells convenient for 
studying some aspects of postsynaptic differentiation. We 
found that a G alNAc-specific lectin, Vicia Villosa agglutinin 
B4 (VVA-B4), selectively stained AChR-rich portions of the 
myotube surface, demonstrating that GalNAc-terminated 
glycoconjugates (VVA-B4 receptors [VVARs]) are coclus- 
tered with AChRs. Based on this result, we asked whether 
VVA-B4, GalNAc-protein conjugates, or GalNAc-degrading 
enzymes could affect the formation of AChR clusters. In 
particular, we focused on the clustering induced by agrin, 
a nerve-derived protein that is believed to induce differenti- 
ation of the postsynaptic membrane in vivo (McMahan, 
1990; McMahan et al., 1992; Campanelli et al., 1992; Nas- 
tuk and Fallon, 1993) and has been shown to promote 
AChR clustering in C2 myotubes (Ferns et al., 1992, 1993). 
Our results implicate VVARs in the control of AChR clus- 
tering and raise the possibility that agrin acts through a 
GalNAc-dependent mechanism. 
Results 
VVARS Are Concentrated at AChR-Rich Hot Spots 
We began this study by assessing the distribution of 
VVARs on C2 myotubes. C2 myoblasts were grown in rich 
medium until they were almost confluent, then switched 
to a serum-poor medium to inhibit further proliferation and 
induce formation of myotubes. Three to four days after 
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Figure 1. Colocalization of VVARs and AChR Clusters 
C2 myotubes were doubly stained with rhodamine-(~-bungarotoxin (a-c)and fluorescein-VVA-B4 (a'-c' and d). In (d), 20 mM GalNAc was included 
to show specificity of staining. (e) shows C2 myoblasts stained with fluorescein-VVA-B4. Bar, 30 ~m (a, d, and e); 10 i~m (b and c). 
fusion was initiated, cultures were double-labeled with rho- 
damine-(~-bungarotoxin to stain AChRs and fluorescein- 
VVA-B4 to stain GalNac-terminated glycoconjugates. As 
shown in Figure 1, VVA-B4 selectively stained AChR clus- 
ters. In addition, a low level of VVA-B4 staining was some- 
times seen along the remainder of the myotube and in 
the extracellular matrix (Figures la  and lc). Myoblasts 
probably contributed some of these diffuse VVARs; VVA- 
B4 intensely stained the matrix secreted by proliferating 
myoblasts (Figure le), and matrix was most intensely 
stained in areas of myotube cultures that were especially 
cell dense and/or contained accumulations of unfused mo- 
nonucleated cells. In contrast, the selective staining of 
AChR clusters by VVA-B4 was consistent and striking; 
75% of intenselyVVA-B4-stained clusters corresponded 
to AChR clusters, and - 80% of the AChR clusters corre- 
sponded to focal accumulations of VVARs. Moreover, 
most, if not all, AChR clusters were stained by VVA-B4 
to some extent. Labeling by VVA-B4 was eliminated by 
inclusion of 20 mM GalNAc in the staining solution (Figure 
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Table 1. Binding of AChRs to Lectins 
Lectin Treatment % precipitated 
None -Agrin 0.2% 
+Agrin 0.3% 
VVA-B4 -Agrin 0.30/0 
+Agrin 0.2% 
ConA -Agrin 65% 
+Agrin 67% 
c2 myotubes were incubated with '2Sl-labeled (~-bungarotoxin, then 
AChRs were solubilized as described in Experimental Procedures. 
Aliquots of the extract were incubated with underivatized agarose, 
VVA-B4 agarose, or ConA-agarose; following incubation, the agarose 
was pelleted. The pellet and cleared extract were then counted. 
ld), whereas inclusion of 20 mM galactose was without 
effect (data not shown). Thus, carbohydrates that resem- 
ble or contain GalNac termini, VVARs, are concentrated 
at AChR-rich domains in vitro as they are in vivo. 
A simple explanation for the colocalization of AChRs 
and VVARs would be that AChRs are VVARs. However, 
two observations indicate that this is not the case. First, 
within the boundaries of hot spots, patterns of VVA-B4 and 
a-bungarotoxin staining differed (Figures l b and lc). 
Second, AChRs that had been labeled with 12Sl-labeled 
(x-bungarotoxin were not precipitated by VVA-B4-agarose 
in conditions under which they were efficiently precipitated 
by agarose conjugated to a mannose-specific lectin, con- 
canavalin A (Table 1). 
VVA-B4 Induces AChR Clustering 
To ask whether VVARs were involved in AChR clustering, 
we added 50 i~g/ml VVA-B4 to the culture medium 2 days 
after initiation of fusion, a time at which many myotubes 
but few hot spots had formed. After 18 hr, cultures were 
stained with rhodamine-a-bungarotoxin a d examined 
with phase and fluorescence optics. VVA-B4 had no appar- 
ent effect on the number or morphology of myotubes (data 
not shown), but its addition led to an increase in the num- 
ber of AChR clusters (Figures 2a and 2b). The effect was 
seen in numerous experiments, but its magnitude varied 
considerably among experiments. For example, the effect 
was insignificant in the experiment shown in Table 2 but 
greater than 2-fold in the experiment shown in Table 3. 
In general, VVA-B4 appeared to be most effective on myo- 
tubes that already had the highest levels of hot spots in 
the absence of VVA-B4. Knowing this, we tested VVA-B4 
on myotubes that had been treated with soluble extracts 
made from rat brain or chick embryos, both of which have 
been shown to contain components that induce AChR 
Figure 2. VVA-B4 Induces Formation of AChR 
Clusters in the Absence or Presence of Agrin 
Cultured myotubes were treated as indicated 
for 18 hr, then stained with rhodamine-~- 
bungarotoxin. 
(a) Fusion medium alone; (b) VVA-B4 (50 Ilg/ 
ml); (c) agrin (10 ng/ml); (d) agrin and WA-B4; 
(e) VVA-B,-agarose beads; (f) wheat germ ag- 
glutinin-agarose beads. 
(e') and (f') are same fields as (e) and (f) photo- 
graphed with fluorescein optics to show p si- 
tions of beads. Addition f soluble VVA-B4 or 
agrin increased the number of AChR clusters 
per myotube; agrin plus VVA-B4 induced more 
clusters than either alone. AChR clusters also 
formed at points where VVA-B4-agarose beads 
contacted rnyotubes; typically, the clusters 
ringed the points of contact (arrow in [e]). Such 
clusters were not observed with control beads. 
Bar, 30 ~m. 
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Table 2. Stimulation of AChR Clustering by WA-B4 
AChR Clusters per Field 
Conditions -VVA-B4 +WA-B4 
/+VVAB41 x k~j  10o 
None 6 4- 3 9 4- 7 150 
Chick Embryo Extract (CEE) 53 4- 5 159 4- 23 300 
Rat Brain Extract (RBE) 55 4- 2 161 4- 19 293 
Agrin 57 4- 3 141 4- 16 247 
CEE+GalNAc 48 -*- 7 55 ___ 6 114 
RBE+GalNAc 59 _+ 7 63 4- 6 107 
Agrin+GalNac 53 ± 5 58 4- 6 109 
Agrin+Gal 56 4- 5 139 _ 20 248 
All compounds listed were added to C2 myotubes for 24 hr prior to analysis. Chick embryo extract was added at 0.02 embryo equivalent per 
milliliter. Rat brain extract was added at 2.5% (w/v). Recombinant C-terminal agrin was added at 10 ng/ml. N-acetylgalactosamine (GalNAc) and 
galactose (Gal) were added at 20 raM. VVA-B4 was added at 50 ilg/ml. Values are means _+ SEM, n = 7-12. 
clustering (Christian et al., 1978; Salpeter et al., 1982; 
Sanes et al., 1984; Olek et al., 1988). Under these condi- 
tions, VVA-B4 increased AChR clustering dramatically and 
reproducibly (Table 2). The effect of VVA-B4 was GalNAc 
mediated, in that it was blocked by addition of GalNAc to 
the incubation medium (Table 2) and mimicked by each 
of three other lectins that recognize GalNAc-terminated 
glycoconjugates and selectively stain neuromuscular 
junctions (Table 3). In contrast, other sugars (galactose 
and glucose; data not shown) and lectins with other speci- 
ficities (Table 3) were inert. Thus, GalNAc-like glycoconju- 
gates modulate clustering of AChRs. 
Because VVA-B4 binds to myoblasts and extracellular 
matrix, as well as to myotube surfaces (see Figure 1), 
it was not clear where the VVARs that stimulated AChR 
clustering were localized. To study this point, we incu- 
bated cultures with VVA-B4 that had been immobil ized on 
agarose beads. AChR clusters formed on portions of the 
myotube surface that were contacted by VVA-B4-agarose 
(Figure 2e). In contrast, heparin-agarose, wheat germ ag- 
glut inin-agarose, GalNAc-agarose,  and underivatized 
agarose did not induce clustering (Figure 2f; data not 
shown). Thus, VVA-B, induces AChR clustering by a local 
interaction with VVARs on the myotube surface. 
VVA-B4 Potentiates the Clustering Activity of Agrin 
During synapse formation, motor axons induce clustering 
of AChRs at sites of nerve-muscle contact, presumably 
by releasing a factor that acts locally (Hall and Sanes, 
1993). Several lines of evidence suggest that this factor 
is agrin, a cluster-promoting protein that is produced by 
motor neurons, transported to nerve terminals, secreted, 
and incorporated into the basal lamina of the synaptic cleft 
(McMahan, 1990, 1992; Campanell i  et al., 1992; Reist et 
al., 1992; Nastu k and Fallon, 1993). Accordingly, we asked 
whether VVA-B4 could affect the clustering activity of agrin. 
As reported previously (Ferns et al., 1993), an affinity- 
purified recombinant C-terminal fragment of agrin (pro- 
vided by J. Campanel l i  and R. Scheller, Stanford Univer- 
sity) was a potent promoter of AChR clustering on C2 
myotubes, exerting a stronger effect than the highest con- 
centrations of VVA-B4 tested (Figure 2c). However, addi- 
tion of VVA-B, potentiated the effect of agrin (Figure 2d; 
Table 2). In some experiments, it appeared that AChR 
clusters induced by agrin plus VVA-B4 were smaller than 
those induced by either agent on its own (Figure 2d); how- 
ever, this effect was not reproducible. As with VVA-B, 
alone, VVA-B4-induced potentiation of the effect of agrin 
was blocked by GalNAc, but not by galactose, and was 
Table 3. Specificity of Lectin-lnduced AChR Clustering 
Synaptic (S) and AChR Clusters per Field (% of Control) 
Nominal Extrasynaptic (E) 
Specificity Staining -Agrin +Agrin Lectin 
None - 8 4- 2 (100) 50 4- 3 (100) 
VVA-B4 GalNAc S >> E 21 4- 2 (262) 126 4- 6 (252) 
DBA GalNAc S >> E 19 4- 2 (238) 81 4- 6 (162) 
SBA GalNAc, Gal S > E 19 4- 2 (238) 72 4- 5 (144) 
WFA GalNAc S > E 29 4- 2 (363) 88 4- 5 (176) 
WGA GIcNAc, SA S ~ E 6 4- 2 (75) 15 4- 1 (30) 
PNA GaI-GalNAc S ==- E 11 4- 3 (137) 53 4- 3 (106) 
Lectins were added to C2 myotubes for 6 hr at a concentration of 50 p~g/ml. Recombinant C-terminal agrin was added at a concentration of 10ng/ 
ml. VVA-B4, Vicia villosa agglutinin isolectin 134; DBA, Dolichos biflorus agglutinin; SBA, soybean agglutinin; WFA, Wisteria floribunda gglutinin; 
WGA, wheat germ agglutinin; PNA, peanut agglutinin; GalNAc, N-acetylgalactosamine; Gal, galactose; Man, mannose; GIc, glucose; GIcNAc, 
N-acetylglucosamine; SA, sialic acid. Data on staining of synaptic and extrasynaptic portions of the muscle fiber surface are from Scott et aL 
(1988). Values are means 4- SEM, n = 9-16. 
GalNAc and AChR Clustering 
747 
160" 
¢3 
uJ 
¢ 
120" 
== 
80-  
O 
== ,o! 
0 q 
- AG~N 
20 40 
[WA-B4]  ( p 9/ml ) 
120~ 
100 
80 
60 
40  
2 ( ]  
PFE-LABEL 
TIME ANER VVA-64 ADDITION (HOURS) 
O 120 
u. 100 
~ oo 
u 
== 
=; 
g 
o 
== 
m, 
,= 
b 
40 ¸  
20 ¸  
0 ° • , 
10 20 30 
TIME AFTER WA-tB4 ADDITION (HOURS) 
- - I - -  
" - I - -  
CONTROL VVA-B4  AGRIN AGRIN + 
WA-B4 
Figure 3. Comparison of VVA-B4- and Agrin- 
Induced AChR Clustering 
(a) Myotubes were treated for 18 hr with or with- 
out 10 ng/ml agrin, after which varying concen- 
trations of VVA-B4 were added for an additional 
6hr. 
(b) Myotubes were treated with 10 ng/ml agrin 
for 18 hr, after which VVA-B4 was added at 50 
p~g/ml for the times shown. 
(c) Myotubes were incubated in 10 ng/ml agrin 
for 18 hr, Cells were then washed three times 
in fusion medium, and 50 I~g/ml VVA-B, was 
added for the times indicated. For the data 
marked "Pre-Label," the cells were labeled with 
rhodamine-a-bungaretoxin during the final 
hour of the incubation with agrin. For the cells 
marked "Post-Label," rhodamine-~-bungaro- 
toxin was added for the final hour of the incuba- 
tion with VVA-B,. 
(d) Myotubes were incubated with fusion me- 
dium (control), 50 Ilg/ml VVA-B4, 10 ng/ml 
agrin, or 50 i~g/ml VVA-B4 and 10 ng/ml agrin. 
For the final 3 hr of this incubation, the cells 
were labeled with 5 nM l~l-labeled ~-bungaro- 
toxin. The cells were then washed 4 times in 
PBS, and AChRs were solubilized in lysis 
buffer containing lO/0 Triton X-100. The total 
radioactivity solubilized under each condition 
was compared. Values are mean _+ SD; n = 
6-12. 
mimicked by GalNAc-specific lectins, but not by lectins 
with other specificities (Table 2 and Table 3). (Wheat germ 
agglutinin, which binds sialic acid and N-acetylglucos- 
amine, inhibited agrin-induced AChR clustering, possibly 
because it inhibits agrin binding to muscle cells; Ma et al., 
1993.) 
In a series of assays, we compared the effects of VVA-B4 
and agrin and characterized their interaction. VVA-B4 in- 
duced AChR clustering with a half-maximal concentration 
of about 5 ~g/ml ( -30  nM) both in the presence and the 
absence of agrin (Figure 3a). AChR clusters were induced 
quickly by both agents, being maximal 4-8 hr after addition 
of VVA-B4 in the presence of agrin (Figure 3b) and 6-8 hr 
after addition of agrin in the absence of VVA-B4 (Godfrey 
et al., 1984; Wallace, 1988; see below). As previously re- 
ported for agrin (Godfrey et al., 1984; Wallace, 1988), VVA- 
B, promoted aggregation of AChRs that were already on 
the cell surface before the lectin was added, as shown by 
comparing myotubes labeled with rhodamine-~-bungaro- 
toxin before or after addition of VVA-B4 (Figure 3c). More- 
over, both agents promoted clustering without detectably 
increasing surface-associated AChRs, as shown by la- 
beling treated and untreated cultures with 1251-labeled 
~-bungarotoxin (Figure 3d). Consistent with its effect on 
preexisting receptors, VVA-B4, like agrin (Wallace, 1988), 
clustered AChRs in the presence of cycloheximide, an 
inhibitor of protein synthesis (data not shown). 
VVA-B4 might potentiate the effect of agrin by binding 
directly to it. To test this possibility, we preincubated an 
aliquot of agrin with a 1000-fold excess of VVA-B4-aga- 
rose, then pelleted the agarose and added the supernatant 
to C2 myotubes. Agrin was just as effective at clustering 
under these conditions (68 _.+ 9 clusters per field; mean 
_.+ SEM) as if it had not been treated with VVA-B4-agarose 
(57 ___ 3 clusters per field), indicating that agrin is not 
a VVAR. We also asked whether agrin bound directly to 
GalNAc by incubating agrin with GalNAc-agarose, then 
pelleting the agarose and testing the supernatant. Again, 
no loss of agrin activity was detected (data not shown). 
Agrin Induces Redistribution of VVARs 
To gain further insight into the relationship of VVARs to 
agrin, we stained agrin-treated myotubes with fluores- 
cein-VVA-B4 and compared them with cells that had not 
been exposed to agrin. As shown in Figure 4, agrin led 
to two striking alterations in the distribution of VVARs on 
the myotube surface. First, agrin induced formation of new 
high density clusters of VVARs; as expected, these clus- 
ters corresponded to AChR-rich hot spots. Second, some 
segments of agrin-treated myotubes and deposits of extra- 
cellular matrix were brightly and diffusely stained by VVA- 
B4. To learn whether AChR clustering preceded or fol- 
lowed VVAR redistribution, cultures were fixed and 
stained 2, 4, 6, 8, and 24 hr after addition of agrin. No 
marked redistribution of either component occurred within 
2 hr, but by 4 hr, AChR clustering and increases in clus- 
tered, diffuse, and matrix-associated VVARs were all 
apparent (Figure 4b). Generally, diffuse and matrix-as- 
sociated VVARs were associated with groups of AChR 
clusters. For example, 24 hr after agrin addition, individual 
cultures contained some areas in which agrin had exerted 
little effect (Figure 4c) and other areas in which the effect 
of agrin had been dramatic (Figure 4d); little diffuse VVA-B4 
staining was apparent in regions of low AChR clustering 
(Figure 4c'), whereas VVA-B4 staining was dramatically 
increased in cluster-rich areas (Figure 4d'). Thus, the 
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Figure4. Agrin Induces Redistribution of 
WARs and AChRs on Myotubes 
Myotubes were left untreated (a) or treated with 
10 ng/ml agrin for 4 hr (b) or for 24 hr (c and 
d). All cultures were then double-stained with 
rhodamine-~-bungarotoxin (a-d) and fluores- 
cein-VVA-B4 (a'-d'). Bar, 30 p.m. 
agrin-induced redistributions of AChRs and of VVARs are 
both temporal ly and regionally correlated. 
Agrin-lnduced AChR Clustering 
Is GalNAc Dependent 
The effects of agrin on the distribution of VVARs and 
AChRs raised the possibility that agrin-induced AChR 
clustering might involve a GalNAc-dependent step. We 
tested this possibility in three ways. First, we removed 
VVARs from the cell surface by adding ~-N-acetylhexosa- 
minidase to the cells during agrin treatment. A 13-specific 
rather than an o-specific enzyme was used because syn- 
aptic VVARs are in the 13 form (Scott et al., 1988). However, 
this enzyme removes both GalNAc and N-acetylglucos- 
amine residues. Treatment with ~-N-acetylhexosamini- 
dase removed VVARs from the cell surface, inhibited 
agrin-induced AChR clustering, and prevented agrin- 
induced VVAR redistribution (Table 4; compare Figure 5a 
with Figure 4b). I~-N-acetylhexosaminidase from each of 
two sources (jack bean and bovine epididymis) had similar 
effects, whereas neither of two enzymes that modify widely 
distributed cell surface carbohydrates, 13-galactosidase 
and sulfatase, affected the ability of agrin to induce AChR 
clusters (Table 4). I~-N-acetylhexosaminidase led to rapid 
dispersal of clusters when it was added following pretreat- 
merit with agrin, indicating that the targets of enzyme ac- 
tion were associated with the cells rather than with the 
agrin (data not shown), To test the possibility that the 
13-N-acetylhexosaminidase treatment had a direct effect 
on AChRs, we tested it on fibroblasts that had been 
transfected with cDNAs encoding the ~, 13, ~', and ,5 AChR 
subunits. Such cells express functional AChRs diffusely 
on their surface, but further addition of the 43K AChR- 
associated cytoskeletal protein induces the formation of 
small AChR clusters (Phillips et al., 1991, 1993). Addition 
of VVA-B4 had no effect on AChR distribution (data not 
Table 4. Effect of GalNAc Manipulation on AChR Clustering 
AChR Clusters 
Conditions per Field 
None 6 _+ 3 
Agrin 54 __. 5 
Neuraminidase 55 --_ 8 
Agrin + ~-N-acetylhexosaminidase 1 7 -4- 3 
Agrin + I~-N-acetylhexosaminidase A 8 + 1 
Agrin + I~-N-acetylhexosaminidase B 6 -*- 1
Agrin + Sulfatase 51 ~ 3 
Agrin + ~-Galactosidase 53 _+_3 
Compounds were added to C2 myotubes for 6 hours. Enzyme sources 
and amounts were as follows: 0.1 U neuraminidase from Clostridium 
perfringens; 0.5 U J~-N-acetylhexosaminidase 1 from Jack Bean; 0.05 
U I~-N-acetylhexosaminidase type A from bovine epididymis; 0.05 U 
13-N-acetylhexosaminidase type B from bovine epididymis; 10 U sul- 
fatase from Helix pomatia; 10 U I~-galactosidase from E. coll. VVA-B4 
was added at 50 p.g/ml and agrin (where indicated) at 10 ng/ml. Values 
are means +_ SEM; n = 10-20 measurements. 
a 
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Figure 5. 13-N-Acetylhexosaminidase Inhibits and Neuraminidase Induces AChR Clustering in C2 Cells but Not in QF18 Cells 
Myotubes were treated with 10 ng/ml agrin and 0.05 U ~-N-acetylhexosaminidase for 6 hr (a) or 0.1 U neuraminidase for 6 hr (b). In (b'), VVARs 
are so abundant throughout the myotube surface that accumulations atAChR-rich hot spots are no longer visible. QF18 cells were treated with 
(c) or without (d) 0.1 U neuraminidase for 18 hr. QF18 cells transfected with a cDNA encoding the 43K protein were treated with (e) or without (f) 
0.5 U of ~-hexosaminidase for18 hr. The cells were stained with rhodamine-~-bungarotoxin (a-f) and fluorescein-VVA-B~ (a' and b~. Bars, 30 ~m. 
shown), and addition of 13-N-acetylhexosaminidase had no 
effect on 43K-induced AChR clustering (Figures 5c and 
5d). Thus, agrin-dependent clustering of AChRs on myo- 
tubes requires N-acetylhexosaminyl-terminated glycocon- 
jugates, but 43K-dependent clustering in nonmuscle cells 
does not. 
Second, we asked whether an agrin-independent in- 
crease in cell surface VVARs could induce AChR cluster- 
ing. Neuraminidase treatment of many tissues increases 
staining by GalNac-specific lectins, presumably because 
many GaINAc residues are normally masked by sialic acid 
(e.g., Laitinen et al., 1989). Likewise, extrasynaptic por- 
tions of the muscle fiber surface, which are normally VVA- 
B4 negative, become VVA-B4 positive following neuramini- 
dase treatment of muscle sections (Iglesias et al., 1992; 
L. Scott, unpublished data). Based on these results, we 
incubated live C2 myotubes with neuraminidase, then 
stained them with rhodamine-a-bungarotoxin and fluores- 
cein-VVA-B4. Neuraminidase treatment led to an increase 
in the intensity of staining by VVA-B4 (Figure 5b~ and to 
a - 10-fold increase in the number of AChR clusters per 
myotube (Table 4). This treatment did not affect AChR 
levels on the cell surface (measured with 12~l-labeled bun- 
garotoxin; data not shown), indicating that clustering was 
not an indirect effect of increased AChR expression. Neur- 
aminidase was equally effective in serum-containing and 
serum-free medium, indicating that the enzyme promoted 
clustering via its action on muscle, rather than by un- 
masking a latent clustering factor in serum (data not 
shown). Neuraminidase did not induce formation of AChR 
clusters on AChR-transfected fibroblasts (Figure 5e and 
5f). Thus, enzymatic generation of new VVARs leads to 
agrin-independent AChR clustering on myotubes but not 
on nonmuscle cells. 
Finally, we tested soluble GalNAc-containing com- 
pounds as inhibitors of agrin. Although GalNAc itself did 
not block agrin-induced AChR clustering (see Table 2), we 
were aware that many mammalian lectins show a marked 
preference for multivalent sugars (Lee and Lee, 1994). 
Therefore, in the hopes of increasing the avidity of a puta- 
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Figure 6. Inhibition of Agrin-lnduced AChR Clustering by GalNAc- 
Protein Conjugates 
(a) 10 ng/ml of agrin was added to myotubes in the presence of the 
indicated BSA-sugar conjugates for 6 hr. 
(b) A myotube from a culture that had been treated with agrin for 6 
hr in the presence of 300 ~g/ml BSA-~-GalNAc, then stained with 
rhodamine-a-bungarotoxin. Bar,30 pro. 
tive GalNAc-binding protein for its ligand, we tested a bo- 
vine serum albumin (BSA)-GalNAc conjugate, prepared 
at a nominal ratio of 15-20 GalNAc residues per molecule 
of BSA. BSA-GalNAc blocked agrin-induced clustering 
of AChRs almost completely at 50 pg/ml, whereas BSA- 
N-acetylglucosamine, BSA-glucose, and BSA alone were 
inert at 10-fold higher concentrations (Figure 6a). One 
plausible xplanation for this result (see Discussion)is that 
there is an endogenous GalNAc-selective lectin in muscle 
that is involved in AChR clustering. Interestingly, in the 
presence of BSA-GalNac, agrin induced formation of very 
small AChR-rich patches (Figure 6b), which were clearly 
distinguishable from hot spots and were seldom observed 
on untreated myotubes. 
Detection of VVA-B4-Binding Proteins in 
C2 Cell Membranes 
To understand how GalNAc-like carbohydrates affect 
AChR clustering, it will be necessarY to identify the bioac- 
tive VVARs of C2 cells. As a first step toward this goal, 
we prepared lysates or membranes from C2 myotubes, 
Figure 7. Biochemical Detection of VVARs in C2 Myotubes 
Membranes were prepared from C2 myotubes, fractionated by gel 
electrophoresis, transferred to nitrocellulose, and probed with biotinyl- 
ated VVA-B4. Some cultures were treated with agrin for 24 hr before 
harvesting. GalNAc (20 m M) was added to the VVA-B4 where indicated. 
Arrow shows position of a-dystroglycan, determined by imrnunoblot- 
ting an adjacent lane. 
fractionated them by gel electrophoresis, transferred them 
to nitrocellulose membranes, and probed the membranes 
with biotinylated VVAoB4. As shown in the first lane of Fig- 
ure 7, VVA-B4 bound to at least 15 distinct glycoproteins 
in the membrane-enriched fraction. A similar pattern was 
observed when whole-cell ysates were probed (data not 
shown). Binding to all but a few of the bands is specific, 
in that it was abolished by addition of 20 mM GalNAc to 
the lectin solution (Figure 7, lane 3). No differences were 
detected between control myotubes and myotubes that 
had been treated with agrin for 24 hr before harvesting 
(Figure 7, lanes 1 and 2). 
Recent reports from four laboratories have identified a 
dystrophin-associated glycoprotein, ~-dystroglycan, as a 
major agrin-binding component of muscle cells (Bowe et 
al., 1994; Gee et al., 1994; Campanelli et al., 1994; Sugi- 
yama et al., 1994). To ask whether a-dystroglycan is a 
VVAR, we probed adjacent lanes from a gel with VVA-B4 
and an antiserum to a-dystroglycan (Ibraghimov-Beskrov- 
naya et al., 1992). No prominent VVA-B4-reactive bands 
comigrated with ~-dystroglycan (arrow in Figure 7). This 
result is consistent with those of Ervasti and Campbell 
(1991), who previously reported that hexosaminidase has 
no detectable ffect on the electrophoretic mobility of rab- 
bit muscle dystroglycan. Thus, we obtained no evidence 
that ~-dystroglycan is a VVAR, although we cannot claim 
to have ruled out this possibility. 
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Figure 8. Possible Interactions of Agrin- and GalNAc-Dependent 
Mechanisms for AChR Clustering 
VVA-B4 activates GalNAc-terminated glycoconjugates (VVA-B4), lead- 
ing to formation of AChR clusters. As detailed in the Discussion, agrin 
could increase the level of VVARs (1), activate VVARs (2), bind to 
VVARs (3), or act synergistically with VVARs (4). 
Discussion 
Carbohydrates that contain or resemble terminal GalNAc 
residues are concentrated at the neuromuscular junction 
in vivo (Sanes and Cheney, 1982; Scott et al., 1988) and 
at nerve-induced (Sanes and Cheney, 1982) and sponta- 
neously occurring (see Figure 1) AChR clusters in vitro. 
In seeking roles for this synapse-associated carbohydrate, 
we discovered that the GalNAc-specific lectin, VVA-B4, 
can induce AChR clustering. We propose that VVA-B4 in- 
duces clustering by binding to GalNAc-terminated glyco- 
conjugates (VVARs) because it is inhibited by soluble 
GalNAc (see Table 2) and mimicked by other GalNAc- 
specific lectins (see Table 3). The relevant VVARs appear 
to be associated with the myotube surface and to act lo- 
cally, since VVA-B4-agarose beads induce clusters at 
points of contact with myotubes (see Figure 2). Since VVA- 
B4 has no known enzymatic activity, activation of VVARs 
could result from occupancy per se or from cross-linking 
by the multivalent lectin tetramer (Tollefsen and Kornfeld, 
1983). These results support the suggestion (Scott et al., 
1988) that the GalNAc-terminated glycoconjugates play a 
role in directing the localization of synaptic components. 
Additional experiments howed that VVA-B4 can potenti- 
ate the AChR clustering induced by agrin. Numerous 
agents are capable of inducing AChR clusters on cultured 
myotubes, including tissue extracts, extracellular matrix 
components, growth factors, and even latex beads (Hall 
and Sanes, 1993). Some of these agents may act in ways 
that are of little biological significance. However, several 
observations uggest that VVARs may be part of the path- 
way by which agrin, the best-characterized clustering 
agent, acts. First, agrin leads to a rapid redistribution of 
myotube-associated VVARs (see Figure 4). Second, treat- 
ment of myotubes with ~-N-acetylhexosaminidase, which 
removes VVARs from the cell surface, inhibits the activity 
of agrin (see Table 4). Third, treatment of myotubes with 
neuraminidase, which increases the density of VVARs on 
myotubes, mimics the effect of agrin (see Table 4). Finally, 
a GalNAc-protein conjugate (GalNAc-BSA) inhibits agrin 
(see Figure 6). Together, these results suggest that agrin- 
induced AChR clustering is GalNAc dependent. 
In considering how VVA-B4 might act, two questions are 
particularly pertinent; is there an endogenous VVA-B4-1ike 
molecule, and how does agrin interact with VVARs? With 
respect o the first of these issues, it is possible that VVA-B4 
activates molecules that happen to bear GalNAc residues 
but normally interact with carbohydrate-independent li-
gands. Many precedents for such an interaction are 
known. For example, antibodies to the insulin receptor 
can cross-link insulin receptors and thereby mimic the ef- 
fects of insulin (Kahn et al., 1978); plant lectins can cross- 
link glycoproteins on lymphocytes and thereby activate 
immune responses (Brown and Hunt, 1978). In neither 
of these cases is the experimental perturbant structurally 
related to the endogenous ligand. On the other hand, two 
sets of observations favor the possibility that there is an 
endogenous GalNAc-binding molecule. First are the re- 
sults that motivated the present study, that multiple 
GalNAc-terminated glycoconjugates are concentrated at 
neuromuscular junctions of numerous vertebrate species 
(see Introduction). This pattern of expression suggests 
that the GalNAc-terminated carbohydrate is itself im- 
portant. Second, the ability of GalNAc-protein conjugates 
to inhibit agrin-induced clustering suggests that GalNAc 
itself, rather than only the molecule to which it is attached, 
is involved in the clustering process. In this context, it 
is worth noting that a GalNAc-inhibitable lectin has been 
isolated from avian muscle (Ceri et al., 1981; Ceri and 
Roberts, 1985). Interestingly, although GalNAc selectively 
inhibits this lectin, the apparent affinity of the interaction 
is low, a property that could explain why GalNAc-BSA 
(which is multivalent) can inhibit agrin but GalNAc itself 
cannot (see Lee and Lee, 1994). 
As to the interaction of agrin with VVARs, we can envi- 
sion four possibilities (Figure 8). First, agrin might promote 
formation of cell surface VVARs. For example, agrin could 
increase the amount of the glycoconjugate (e.g., by acti- 
vating a GalNAc transferase); it could unmask GalNAc 
residues (e.g., by activating a neuraminidase); or it could 
lead to externalization of intracellular glycoconjugates 
(e.g., as insulin does for glucose transporters; Mueckler, 
1994). In favor of this class of mechanism is the observa- 
tion that neuraminidase induces AChR clustering in the 
absence of agrin. 
Second, agrin could lead to activation of preexisting cell 
surface VVARs, for example, via effects on the cytoskele- 
ton or via activation of a kinase (Wallace, 1992). We have 
no evidence for or against this possibility. 
Third, the binding of agrin to its receptor might be 
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GalNAc dependent.  A precedent for this model  is provided 
by basic f ibroblast growth factor, which must bind both to 
a g lycoconjugate (heparan sulphate proteoglycan) and to 
a membrane-associated receptor tyrosine kinase to acti- 
vate the kinase and thereby transduce a signal to the inte- 
rior of the cell (Rapraeger  et al., 1991 ; Yayon et al., 1991). 
It is also possible that the signal-transducing agrin recep- 
tor is itself a VVAR,  although we have been unable to 
show that the only agrin-binding protein identified to date, 
a-dystroglycan, bears terminal GalNAc residues (see Fig- 
ure 7; see also Ervasti and Campbel l ,  1991). In this 
scheme, it is not clear why VVA-B4 would potentiate the 
effect of agrin. However,  s ince differences in eff icacy have 
been documented between soluble, truncated forms of 
agrin (such as the C-terminal fragment we used here) and 
full-length, cel l-associated forms (Ferns et al., 1993), it is 
possible that VVA-B4 can mimic or replace a sugar-binding 
activity that is normal ly mediated by the N-terminal frag- 
ment of agrin or by an agrin-associated protein. 
Finally, agrin and VVARs might act through separate 
pathways, with activation of the GalNAc-dependent  mech- 
anism being necessary for optimal induction of AChR clus- 
tering by agrin. In this case, one might imagine that nor- 
mally occurr ing levels of VVARs  are sufficient to support 
some activation by agrin but are rate limiting. Thus, alter- 
ations in the level or aggregat ion state of VVARs would 
affect the extent of cluster formation in either the absence 
or presence of agrin. Our current efforts focus on testing 
these and other possibil it ies by identifying those VVARs, 
among the many present in C2 cells, that affect AChR 
clustering. 
Experimental Procedures 
Cell Culture 
The C2C12 subclone of the C2 cell line was obtained from ATCC 
(Bethesda, MD) and grown on gelatin-coated ishes in Dulbecco's 
modified Eagle's medium (DMEM) supplemented with penicillin, strep- 
tomycin, and 20% fetal calf serum. For histological studies, cells were 
trypsinized and replated on gelatin-coated 12 mm circular glass cov- 
erslips, grown to confluence, and induced to fuse by transfer to DMEM 
containing 2% horse serum with penicillin and streptomycin. Cells 
were switched to fusion medium 3-4 days prior to treatment with one 
or more of the following: lectins (Sigma Chemicals, St. Louis, MO; see 
Table 3), rat brain extract (Sanes et al., 1984), chick embryo extract, 
affinity-purified recombinant C-terminal fragment of agrin (the gener- 
ous gift of J. Campanelli and R. Scheller, Stanford University; Ferns 
et al., 1993), BSA-sugar conjugates (Sigma and Biocarb, Lund, Swe- 
den), and sugar hydrolyzing enzymes (Sigma; see Table 4). The BSA- 
sugar conjugates were washed in a 10,000 molecular weight filter 
(Millipore) with 16 volumes of distilled water prior to usage. 
Fibroblasts stably transfected with AChR subunit cDNAs (QF18 
cells; Phillips et al., 1991; gift of John Merlie) were grown in Earle's 
199 with 5% fetal calf serum, 10% tryptose phosphate broth, 1% di- 
methylsulfoxide, penicillin, and streptomycin. Cells were transfected 
with pRSVM43, which encodes 43K, as described by Maimone and 
Merlie (1993). 
Fluorescence Microscopy 
AChRs were labeled by incubating live cells for 1 hr with 50 ng/ml 
monovalent rhodamine-~-bungarotoxin (gift of Jeff Lichtman or pur- 
chased from Molecular Probes, Eugene, OR). The cells were then 
washed in phosphate-buffered saline (PBS), fixed for 20 min in 1% 
paraformaldehyde in PBS, rinsed with PBS, and then washed with 
PBS containing 10% goat serum. To label VVARs, the fixed and 
washed cells were incubated with 5 pg/ml fluorescein-conjugated 
VVA-B4 (Sigma) for 30 min in PBS with 10% goat serum, then washed 
for 30 min. AChR clusters were then viewed with a 40 x oil-immersion 
objective counted in 10-20 visual fields per covers,p, with at least 2 
coverslips counted per treatment. AChR-rich areas />5 I~m in length 
were counted as clusters. When the extent of clustering was especially 
variable, more fields were counted until a standard error ~< 10% of the 
mean was achieved. 
Lectin Precipitation of AChRs 
Live cells were labeled with 5 nM ~2~l-labeled bungarotoxin (monova- 
lent) for 3 hr at 37°C, then washed 4 times with PBS. The cells were 
then lysed in ice cold lysis buffer containing PBS with 1 mM EDTA, 
1 mM phenylmethylsulfonyl fluoride, and 1% Triton X-100. After solu- 
bilization, the lysate was spun for 3 min at 15,000 x g. The supernatant 
was transferred to tubes containing enough VVA-B4-agarose or ConA- 
agarose to bind 10 I~g of sugar and incubated for 18 hr with gentle 
shaking at 4°C. In some experiments, 1 mM CaCI2 was added to the 
incubation solution to maximize activity of VVA-B4. Following incuba- 
tion, the agarose was centrifuged for 1 min at 15000 x g and the 
supernatant removed and counted in a gamma counter. The pellet 
was then washed three times in lysis buffer and counted. The binding 
capacity of VVA-B4-agarose was confirmed by incubation with (and 
precipitation of) BSA-GaINAc (Sigma). 
Lectin Blotting 
C2 myotubes were grown on 15 cm diameter dishes and harvested 
in reducing SDS gel buffer to prepare whole-cell lysates. Alternatively, 
a membrane-rich fraction was prepared from the cells. For this pur- 
pose, C2 myotubes were washed with PBS, then the following buffer 
was added: 50 mM Tris (pH 7.0), 2 m M EDTA, 2 mM phenylmethylsulfo- 
nyl fluoride, 10 ~tg/ml leupeptin, 20 I~g/ml aprotinin, and 20 p,g/ml 
chicken trypsin inhibitor (Sigma). Cells were then lysed using 20 
strokes of a Dounce homogenizer. Unbroken cells and nuclei were 
removed by pelleting at 2000 x g for 3 min. The supernatant was 
centrifuged at 100,000 x g for 1 hr, and the resulting membrane pellet 
was solubilized by boiling in reducing SDS gel buffer. 
Proteins were separated by reducing polyacrylamide gel electropho- 
resis on 10% acrylamide gels. Proteins were transferred to nitrocellu- 
lose overnight in 50 mM Tris (pH 8.8), 380 mM glycine, 0.10/0 SDS, 
and 20% methanol. The nitrocellulose was blocked in buffer containing 
10 mM Tris (pH 8.0), 150 mM NaCI, 0.2 mM EDTA, 0.1% Tween 20, and 
1 mg/ml BSA. Membranes were incubated with biotinylated VVA-B4 at 
a concentration of 5 I~g/ml with or without 20 mM GalNAc, washed, and 
incubated with alkaline phosphatase-coupled streptavidin (Boehringer 
Mannheim). An adjacent lane was blotted with antiserum FP-D, which 
recognizes c~-dystroglycan (Ibraghimov-Beskrovnaya et al., 1992), fol- 
lowed by alkaline-phosphatase-coupled donkey-m-sheep secondary 
antibody (Sigma). Blots were developed using 5-bromo-4-chloro-3- 
indolyl phosphate as substrate. 
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